We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$735M
AUM Growth
+$91.2M
Cap. Flow
+$63.4M
Cap. Flow %
8.63%
Top 10 Hldgs %
24.07%
Holding
118
New
17
Increased
44
Reduced
5
Closed
14

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.4M
2
SYNA icon
Synaptics
SYNA
+$9.97M
3
DATA
Tableau Software, Inc.
DATA
+$9.41M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.8M
5
AKBA icon
Akebia Therapeutics
AKBA
+$4M

Top Sells

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$4.68M
2
SJM icon
J.M. Smucker
SJM
+$4.51M
3
NOV icon
NOV
NOV
+$3.7M
4
PCYC
PHARMACYCLICS INC
PCYC
+$2.7M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$2.33M

Sector Composition

Rank Sector Weight
1 Healthcare 26.56%
2 Technology 14.37%
3 Consumer Discretionary 13.18%
4 Industrials 9.24%
5 Materials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIRX
101
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$599K 0.08%
437
– –
RPTP
102
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$467K 0.06%
40,400
– –
QURE icon
103
uniQure
QURE
$2.93B
$292K 0.04%
+21,466
New +$234K
VSTM icon
104
Verastem
VSTM
$536M
$189K 0.03%
+1,742
New +$189K
CERS icon
105
Cerus
CERS
$579M
– –
-97,800
Closed -$469K
CTRA
106
DELISTED
Coterra Energy
CTRA
– –
-35,200
Closed -$1.19M
NOV icon
107
NOV
NOV
$6.88B
– –
-52,678
Closed -$3.7M
PBYI icon
108
Puma Biotechnology
PBYI
$402M
– –
-44,900
Closed -$4.68M
PRTA icon
109
Prothena Corp
PRTA
$440M
– –
-58,300
Closed -$2.23M
RMD icon
110
ResMed
RMD
$30.3B
– –
-9,900
Closed -$442K
SJM icon
111
J.M. Smucker
SJM
$13.1B
– –
-46,400
Closed -$4.51M
CLVS
112
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-28,300
Closed -$1.96M
ATHX
113
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-10,612
Closed -$860K
ECYT
114
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-98,000
Closed -$2.33M
FMI
115
DELISTED
Foundation Medicine, Inc.
FMI
– –
-49,200
Closed -$1.59M
HTWR
116
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-3,100
Closed -$291K
MDAS
117
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
– –
-26,500
Closed -$655K
SHPG
118
DELISTED
Shire pic
SHPG
– –
-9,800
Closed -$1.46M
1 2 3 4
5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Eventide Asset Management held 118 positions worth $735M, up 14% from $644M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $63.4M of net new capital in Q2 2014, opening 17 new positions and adding to 44 existing holdings. Its largest new stake was Celgene Corp: 190,000 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was PHARMACYCLICS INC, an estimated $2.7M trimmed.

  • Eventide Asset Management's largest Q2 2014 buy was Celgene Corp: 190,000 shares worth $16.3M.
  • Eventide Asset Management added most to Acadia Pharmaceuticals in Q2 2014, an estimated $4.8M increase.
  • Eventide Asset Management's biggest Q2 2014 reduction was PHARMACYCLICS INC, cutting an estimated $2.7M.
  • Eventide Asset Management fully exited Puma Biotechnology in Q2 2014, selling an estimated $4.68M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $735M portfolio in Q2 2014.
  • Eventide Asset Management opened 17 new positions and closed 14 in Q2 2014.
  • Eventide Asset Management's portfolio value rose 14% quarter-over-quarter to $735M.

Based on Eventide Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.